The Toronto Helicobacter pylori Consensus in Context David Y. Graham  Gastroenterology  Volume 151, Issue 1, Pages 9-12 (July 2016) DOI: 10.1053/j.gastro.2016.05.009 Copyright © 2016 Terms and Conditions

Figure 1 Helicobacter pylori eradication rates with proton pump inhibitor triple therapy in populations with varying proportions of clarithromycin resistance. Based on a theoretical population where the cure rate is 95% with susceptible infections and 15% with resistant infections. Gastroenterology 2016 151, 9-12DOI: (10.1053/j.gastro.2016.05.009) Copyright © 2016 Terms and Conditions

Figure 2 Example of one possible set of recommendations for susceptibility-based first-line Helicobacter pylori therapy. This example is based on the premises that it is preferable to minimize the use of unnecessary antibiotics and that proton pump inhibitors, amoxicillin, and third drug triple therapies are usually better tolerated than bismuth quadruple therapy. Gastroenterology 2016 151, 9-12DOI: (10.1053/j.gastro.2016.05.009) Copyright © 2016 Terms and Conditions